Competing interests
Parkinson’s disease
International patent applications relating to the use of nicotinamide riboside as a treatment for Parkinson’s disease have been filed by the Technology Transfer Office “Vestlandets Innovasjonsselskap As (VIS)” on behalf of Haukeland University Hospital, Bergen, Norway, with publication authors C.T. and C.D. as inventors. The applications are pending and have the application numbers: PCT/EP2022/067408, PCT/EP2022/067412 and PCT/EP2023/060962. All other authors declare no competing interests.